Zim Laboratories Ltd

NSE: ZIMLAB · BSE: 541400 · Pharmaceuticals & Biotechnology · 39 announcements

Share price: ₹134.66
Market cap: ₹722.6 Cr
Revenue (annual): ₹374.4 Cr
Net profit (annual): ₹5.84 Cr
P/E (TTM): 348.8×Sector 43.8×
Promoter holding: 30.30%-0.06% QoQ
FII holding: 0.17%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Annual General Meeting 5 Financial Results 4 Merger & Restructuring 3 Employee Stock Options 3 Regulatory Approval 2 Promoter Buying (Off-Market) 2 Other Announcement 2 Board Meeting Date 2 Management Change 1 Credit Rating 1 Annual Report 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

32 announcements with these filters

19 May 2026 16:42 IST NSE

Financial Results

Zim Laboratories Q4 FY26 Results: Net Profit ₹3.7 Cr, Down 24.5% YoY

Zim Laboratories Ltd reported revenue from operations of ₹105.3 Cr (-3.1% YoY) and net profit of ₹3.7 Cr (-24.5% YoY) for Q4 FY26.

Key figure: Net profit ₹3.7 Cr · -24.5% YoY

Open full results → Read the filing ↗

19 May 2026 16:41 IST NSE

Financial Results

Zim Laboratories Financial Results

Zim Laboratories reported annual consolidated total income of ₹385.78 Crore for FY26. The Board also appointed M/s Dhananjay V. Joshi & Associates as Cost Auditors.

Value: ₹385.8 Cr

Open announcement → Read the filing ↗